Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05469178
Title A Study to Investigate the Safety, Tolerability, and Preliminary Anti-tumor Activity of Bemcentinib in Combination With Pembrolizumab Plus Pemetrexed and Carboplatin in Adult Participants With Untreated Non-squamous Non-small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors BerGenBio ASA
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mount Sinai Comprehensive Cancer Center RECRUITING Miami Beach Florida 33140 United States Details
Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland RECRUITING Baltimore Maryland 21201 United States Details
Icahn School of Medicine at Mount Sinai RECRUITING New York New York 10029 United States Details
Tennessee Oncology PLLC RECRUITING Nashville Tennessee 37203 United States Details
UT Southwestern Medical Center RECRUITING Dallas Texas 75390 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field